IMNM vs MKC · $2.47B cap vs P/E 8.4, rev $3.81B
Immunome Inc (IMNM) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported MKC revenue for 2026-05-31 was $3.81B. Net income was $1.17B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
IMNM currently screens at market cap $2.47B. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the IMNM and MKC stock pages for the full models.
Not investment advice.